杰龙制药 GERN
$0.99 +$0.04 (+4.18%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $0.99 -0.15%
开盘$0.95
昨收$0.95
当日区间$0.95 – $1.02
成交量13.65M
市值$637.67M
市盈率（TTM）–
股息率–
GERN 相关新闻
匹配 Geron 或代码 GERN 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Geron(GERN.US) With Hold Rating
- Needham Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $4
- TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $3
- Earnings Flash (GERN) Geron Corporation Reports Q2 Revenue $57.5M, Vs. FactSet Est of $55.3M
- 4: Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
- Geron | 4: Statement of changes in beneficial ownership of securities-Director O'Farrell Elizabeth G.
- Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
- Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Geron (GERN)
- Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
- A Quick Look at Today's Ratings for Geron(GERN.US), With a Forecast Between $1 to $4
- Goldman Sachs Maintains Geron(GERN.US) With Sell Rating, Maintains Target Price $1
- Wedbush Maintains Geron(GERN.US) With Buy Rating, Cuts Target Price to $5 负面
- TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $3
- Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
- TD Cowen Maintains Geron(GERN.US) With Buy Rating, Cuts Target Price to $3 负面
暂无评论——快来第一个聊聊 GERN。
登录后参与讨论。